Citation: Da. Kramer et Rb. Conolly, COMPUTER-SIMULATION OF CLONAL GROWTH CANCER MODELS .1. PARAMETER-ESTIMATION USING AN ITERATIVE ABSOLUTE BISECTION ALGORITHM, Risk analysis, 17(1), 1997, pp. 115-126
Authors:
PAGE NP
SINGH DV
FARLAND W
GOODMAN JI
CONOLLY RB
ANDERSEN ME
CLEWELL HJ
FREDERICK CB
YAMASAKI H
LUCIER G
Citation: Np. Page et al., IMPLEMENTATION OF EPA REVISED CANCER ASSESSMENT GUIDELINES - INCORPORATION OF MECHANISTIC AND PHARMACOKINETIC DATA, Fundamental and applied toxicology, 37(1), 1997, pp. 16-36
Citation: Rb. Conolly et Me. Andersen, HEPATIC FOCI IN RATS AFTER DIETHYLNITROSAMINE INITIATION AND 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN PROMOTION - EVALUATION OF A QUANTITATIVE 2-CELL MODEL AND OF CYP 1A1 1A2 AS A DOSIMETER/, Toxicology and applied pharmacology, 146(2), 1997, pp. 281-293
Citation: Eac. Hubal et al., COMPARISON OF INHALED FORMALDEHYDE DOSIMETRY PREDICTIONS WITH DNA-PROTEIN CROSS-LINK MEASUREMENTS IN THE RAT NASAL PASSAGES, Toxicology and applied pharmacology, 143(1), 1997, pp. 47-55
Authors:
KIMBELL JS
GROSS EA
RICHARDSON RB
CONOLLY RB
MORGAN KT
Citation: Js. Kimbell et al., CORRELATION OF REGIONAL FORMALDEHYDE FLUX PREDICTIONS WITH THE DISTRIBUTION OF FORMALDEHYDE-INDUCED SQUAMOUS METAPLASIA IN F344 RAT NASAL PASSAGES, Mutation research, 380(1-2), 1997, pp. 143-154
Citation: M. Casanova et al., DNA-PROTEIN CROSS-LINKS (DPX) AND CELL-PROLIFERATION IN B6C3F(1) MICEBUT NOT SYRIAN GOLDEN-HAMSTERS EXPOSED TO DICHLOROMETHANE - PHARMACOKINETICS AND RISK ASSESSMENT WITH DPX AS DOSIMETER, Fundamental and applied toxicology, 31(1), 1996, pp. 103-116
Authors:
LARSON JL
TEMPLIN MV
WOLF DC
JAMISON KC
LEININGER JR
MERY S
MORGAN KT
WONG BA
CONOLLY RB
BUTTERWORTH BE
Citation: Jl. Larson et al., A 90-DAY CHLOROFORM INHALATION STUDY IN FEMALE AND MALE B6C3F(1) MICE- IMPLICATIONS FOR CANCER RISK ASSESSMENT, Fundamental and applied toxicology, 30(1), 1996, pp. 118-137
Citation: F. Welsch et al., PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS APPLICABLE TO ORGANOGENESIS - EXTRAPOLATION BETWEEN SPECIES AND POTENTIAL USE IN PRENATAL TOXICITY RISK ASSESSMENTS, Toxicology letters, 82-3, 1995, pp. 539-547
Citation: Rb. Conolly et Be. Butterworth, BIOLOGICALLY-BASED DOSE-RESPONSE MODEL FOR HEPATIC TOXICITY - A MECHANISTICALLY BASED REPLACEMENT FOR TRADITIONAL ESTIMATES OF NONCANCER RISK, Toxicology letters, 82-3, 1995, pp. 901-906
Citation: Be. Butterworth et al., A STRATEGY FOR ESTABLISHING MODE OF ACTION OF CHEMICAL CARCINOGENS ASA GUIDE FOR APPROACHES TO RISK ASSESSMENTS, Cancer letters, 93(1), 1995, pp. 129-146
Authors:
CLEWELL HJ
QUINN DW
ANDERSEN ME
CONOLLY RB
Citation: Hj. Clewell et al., AN IMPROVED APPROXIMATION TO THE EXACT SOLUTION OF THE 2-STAGE CLONALGROWTH-MODEL OF CANCER, Risk analysis, 15(4), 1995, pp. 467-473
Authors:
BORGHOFF SJ
GARGAS ML
ANDERSEN ME
CONOLLY RB
Citation: Sj. Borghoff et al., DEVELOPMENT OF A MECHANISM-BASED DOSIMETRY MODEL FOR 2,4,4-TRIMETHYL-2-PENTANOL-INDUCED ALPHA-2U-GLOBULIN NEPHROPATHY IN MALE FISCHER-344 RATS, Fundamental and applied toxicology, 25(1), 1995, pp. 124-137
Citation: Kk. Terry et al., DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL DESCRIBING 2-METHOXYACETIC ACID DISPOSITION IN THE PREGNANT MOUSE, Toxicology and applied pharmacology, 132(1), 1995, pp. 103-114
Authors:
GEARHART JM
JEPSON GW
CLEWELL HJ
ANDERSEN ME
CONOLLY RB
Citation: Jm. Gearhart et al., PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY ORGANOPHOSPHATE ESTERS, Environmental health perspectives, 102, 1994, pp. 51-60
Citation: Rb. Conolly et Js. Kimbell, COMPUTER-SIMULATION OF CELL-GROWTH GOVERNED BY STOCHASTIC-PROCESSES -APPLICATION TO CLONAL GROWTH CANCER MODELS, Toxicology and applied pharmacology, 124(2), 1994, pp. 284-295
Citation: Rb. Conolly et Me. Andersen, AN APPROACH TO MECHANISM-BASED CANCER RISK ASSESSMENT FOR FORMALDEHYDE, Environmental health perspectives, 101, 1993, pp. 169-176
Citation: Do. Clarke et al., PHARMACOKINETICS OF 2-METHOXYETHANOL AND 2-METHOXYACETIC ACID IN THE PREGNANT MOUSE - A PHYSIOLOGICALLY-BASED MATHEMATICAL-MODEL, Toxicology and applied pharmacology, 121(2), 1993, pp. 239-252